Figure 4.
(A–D). Forest plots of relative risk of cardiovascular events of all-grade associated with regorafenib versus control. A. Hypertension; B. Hemorrhage; C. Thrombosis; D. Heart failure.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.